Stratos Wealth Partners’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $757K | Sell |
8,377
-353
| -4% | -$32.4K | 0.01% | 908 |
|
|
2025
Q4 | $785K | Buy |
8,730
+315
| +4% | +$29.9K | 0.01% | 861 |
|
|
2025
Q3 | $829K | Sell |
8,415
-236
| -3% | -$23.4K | 0.01% | 816 |
|
|
2025
Q2 | $789K | Sell |
8,651
-242
| -3% | -$23.4K | 0.01% | 775 |
|
|
2025
Q1 | $1.01M | Sell |
8,893
-680
| -7% | -$72.7K | 0.02% | 660 |
|
|
2024
Q4 | $1.01M | Sell |
9,573
-249
| -3% | -$26.7K | 0.01% | 694 |
|
|
2024
Q3 | $1.06M | Buy |
9,822
+117
| +1% | +$12.8K | 0.02% | 659 |
|
|
2024
Q2 | $1.05M | Sell |
9,705
-217
| -2% | -$25.6K | 0.02% | 631 |
|
|
2024
Q1 | $1.31M | Buy |
9,922
+42
| +0.4% | +$5.25K | 0.02% | 561 |
|
|
2023
Q4 | $1.2M | Buy |
9,880
+402
| +4% | +$44.9K | 0.02% | 560 |
|
|
2023
Q3 | $1.06M | Sell |
9,478
-252
| -3% | -$32K | 0.02% | 553 |
|
|
2023
Q2 | $1.42M | Buy |
9,730
+205
| +2% | +$27.9K | 0.03% | 432 |
|
|
2023
Q1 | $1.23M | Sell |
9,525
-569
| -6% | -$71.4K | 0.03% | 426 |
|
|
2022
Q4 | $1.29M | Buy |
10,094
+249
| +3% | +$28.9K | 0.03% | 444 |
|
|
2022
Q3 | $1.03M | Buy |
9,845
+56
| +0.6% | +$6.14K | 0.03% | 475 |
|
|
2022
Q2 | $1.03M | Sell |
9,789
-135
| -1% | -$16K | 0.03% | 505 |
|
|
2022
Q1 | $1.27M | Sell |
9,924
-398
| -4% | -$48K | 0.03% | 491 |
|
|
2021
Q4 | $1.27M | Sell |
10,322
-149
| -1% | -$19.5K | 0.03% | 494 |
|
|
2021
Q3 | $1.49M | Sell |
10,471
-481
| -4% | -$70.8K | 0.04% | 401 |
|
|
2021
Q2 | $1.71M | Sell |
10,952
-68
| -0.6% | -$11K | 0.04% | 388 |
|
|
2021
Q1 | $1.71M | Sell |
11,020
-153
| -1% | -$23.7K | 0.05% | 345 |
|
|
2020
Q4 | $1.67M | Sell |
11,173
-227
| -2% | -$32.1K | 0.05% | 314 |
|
|
2020
Q3 | $1.51M | Sell |
11,400
-678
| -6% | -$88.6K | 0.05% | 300 |
|
|
2020
Q2 | $1.4M | Sell |
12,078
-851
| -7% | -$98.1K | 0.05% | 317 |
|
|
2020
Q1 | $1.27M | Buy |
12,929
+98
| +0.8% | +$12.8K | 0.06% | 283 |
|
|
2019
Q4 | $1.86M | Buy |
12,831
+399
| +3% | +$55.1K | 0.07% | 253 |
|
|
2019
Q3 | $1.66M | Sell |
12,432
-7,797
| -39% | -$1.01M | 0.07% | 261 |
|
|
2019
Q2 | $2.31M | Buy |
20,229
+666
| +3% | +$78K | 0.1% | 208 |
|
|
2019
Q1 | $2.42M | Buy |
19,563
+23
| +0.1% | +$2.61K | 0.11% | 207 |
|
|
2018
Q4 | $1.97M | Sell |
19,540
-547
| -3% | -$61.5K | 0.1% | 209 |
|
|
2018
Q3 | $2.56M | Buy |
20,087
+491
| +3% | +$58.4K | 0.11% | 189 |
|
|
2018
Q2 | $2.12M | Sell |
19,596
-1,527
| -7% | -$166K | 0.09% | 227 |
|
|
2018
Q1 | $2.24M | Buy |
21,123
+2,662
| +14% | +$309K | 0.09% | 224 |
|
|
2017
Q4 | $2.16M | Buy |
18,461
+260
| +1% | +$29.4K | 0.1% | 218 |
|
|
2017
Q3 | $2.07M | Sell |
18,201
-7,737
| -30% | -$893K | 0.1% | 210 |
|
|
2017
Q2 | $3.23M | Buy |
25,938
+7,623
| +42% | +$904K | 0.17% | 137 |
|
|
2017
Q1 | $2.17M | Buy |
18,315
+2,966
| +19% | +$336K | 0.12% | 164 |
|
|
2016
Q4 | $1.54M | Buy |
15,349
+5,110
| +50% | +$548K | 0.1% | 201 |
|
|
2016
Q3 | $1.29M | Buy |
10,239
+3,474
| +51% | +$429K | 0.09% | 205 |
|
|
2016
Q2 | $791K | Buy |
6,765
+4,089
| +153% | +$463K | 0.06% | 253 |
|
|
2016
Q1 | $277K | Buy |
2,676
+58
| +2% | +$5.61K | 0.02% | 429 |
|
|
2015
Q4 | $261K | Buy |
+2,618
| New | +$256K | 0.02% | 455 |
|
|
2015
Q1 | – | Sell |
-1,883
| Closed | -$207K | – | 636 |
|
|
2014
Q4 | $207K | Buy |
+1,883
| New | +$198K | 0.04% | 441 |
|
Other funds holding ZBH
VCM
VPM
Stratos Wealth Partners's ZBH Position: Q1 2026 in Review
Stratos Wealth Partners reduced its Zimmer Biomet (ZBH) stake by 4% in Q1 2026, selling an estimated $32.4K and leaving 8,377 shares worth $757K. The position accounts for 0.01% of the portfolio, ranked #908.
Stratos Wealth Partners first reported a position in ZBH in Q4 2014 and has held it in 43 quarters since. The position peaked at $3.23M in Q2 2017. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Stratos Wealth Partners held 8,377 shares of Zimmer Biomet worth $757K as of Q1 2026.
- Stratos Wealth Partners sold 353 Zimmer Biomet shares in Q1 2026, an estimated $32.4K.
- Zimmer Biomet made up 0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #908 holding.
- Stratos Wealth Partners first reported a position in Zimmer Biomet in Q4 2014 and has held it in 43 quarters since.
- Stratos Wealth Partners's Zimmer Biomet position peaked at $3.23M in Q2 2017.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.